BPIQ Blog

Dec 30, 20221 min read

Biopharma Pulse - 12/26-12/30 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Dec 28, 20221 min read

TGTX - BRIUMVI (Ublituximab) approval

TGTX BRIUMVI (Ublituximab) approved for MS on 12/28/2022! See the new label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/76...

Dec 23, 20221 min read

Biopharma Pulse - 12/19-12/23 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Dec 23, 20221 min read

Biotech Weekly Catalyst Watchlist Dec 25th 2022

Last week we saw the MDGL NASH data on Monday and it's up over +300%. This next week we see LOTS of PDUFA events happening to close out...

Dec 22, 20223 min read

ESPR Nexletol - Stock back after Clear Outcomes data?

Summary: Esperion CLEAR outcomes data came out Dec 7 This was a month early and stock did not react well (down 15% on 12/7 and 32% that...

Dec 17, 20222 min read

Biotech Weekly Catalyst Watchlist Dec 18th 2022

We're winding down to the end of 2022 but still have lots of major readouts left with year. This includes readouts from companies like...

Dec 16, 20221 min read

Biopharma Pulse - 12/12-12/16 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Dec 16, 20221 min read

Biopharma Pulse - 12/12-12/16 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Dec 15, 20222 min read

J.P. Morgan 2023 Healthcare Conference

(Last updated 12/15/22) The 41st Annual J.P. Morgan Health Care Conference is taking place in San Francisco, AC from January 9-12, 2023. ...

Dec 15, 20221 min read

NASH Companies Back in the Spotlight!

(First posted 12/15/22) NASH is a liver disease that is one of the most challenging diseases for finding effective therapeutics. There...

Dec 9, 20221 min read

BPIQ Biotech Catalyst Watchlist - December 2022

There are a number of biotech catalyst events left in 2022, including FDA/PDUFA events, data readouts, and biomedical meetings. See the...

Dec 9, 20221 min read

Biopharma Pulse - 12/5-12/9 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Dec 2, 20221 min read

Biopharma Pulse - 11/28-12/2 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Nov 25, 20221 min read

Biopharma Pulse - 11/21-11/25 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Nov 18, 20221 min read

Biopharma Pulse - 11/14-11/18 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Nov 17, 20222 min read

San Antonio Breast Cancer Symposium Abstracts Now Published!

Summary: Several companies have already announced presentations at SABCS 2022 (San Antonio Breast Cancer Symposium) Abstracts will...

Nov 17, 20225 min read

BPIQ Q4 2022 Biotech Hedge Fund (13F) Analysis

Last updated 2/24/23 Summary: Hedge fund holdings can help you discover new investment ideas See further detailed analysis of all 36...

Nov 9, 20224 min read

Are Mid-Term Results Good for Biotech Investors?

SUMMARY The drug-price reform focus of Congress affects biopharma stock prices The likelihood that Republicans will control at least the...

Nov 4, 20221 min read

Biopharma Pulse - 10/31-11/4 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Oct 28, 20221 min read

Biopharma Pulse - 10/24-10/28 Week in Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Jump start your biotech due diligence

Get started →

Our platform helps you uncover your next biotech investment opportunity